FDA and Off-Label Communication – Getting Closer to Truth
Drug & Device Law
NOVEMBER 9, 2023
If unfettered truthful off-label promotion is permissible, then the incentives for regulated entities to spend the large amounts of time and money now required to submit new uses of already approved FDA-regulated products for additional approvals would be reduced. The FDA is concerned, probably with reason, about its own power.
64 
Let's personalize your content